KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Gains from Investment Securities (2016 - 2026)

Supernus Pharmaceuticals has reported Gains from Investment Securities over the past 15 years, most recently at -$1.9 million for Q4 2025.

  • Quarterly Gains from Investment Securities fell 103.17% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 97.26% year-over-year, with the annual reading at -$1.9 million for FY2025, 103.54% down from the prior year.
  • Gains from Investment Securities was -$1.9 million for Q4 2025 at Supernus Pharmaceuticals, down from $3.3 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $59.5 million in Q4 2024 and troughed at -$7.7 million in Q2 2021.
  • The 5-year median for Gains from Investment Securities is -$270000.0 (2022), against an average of $2.4 million.
  • Year-over-year, Gains from Investment Securities tumbled 1272.55% in 2021 and then surged 4402.17% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$6.8 million in 2021, then surged by 78.03% to -$1.5 million in 2022, then grew by 6.68% to -$1.4 million in 2023, then surged by 4402.17% to $59.5 million in 2024, then crashed by 103.17% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Gains from Investment Securities are -$1.9 million (Q4 2025), $3.3 million (Q1 2025), and $59.5 million (Q4 2024).